Literature DB >> 19127470

Permutation test following covariate-adaptive randomization in randomized controlled trials.

Takahiro Hasegawa1, Toshiro Tango.   

Abstract

In randomized controlled trials, patients are recruited and randomly allocated to treatments. Patients are never randomly sampled from large population of patients on treatments under study. Therefore, it is important to consider the design and statistical analysis based on the randomization model. In this article, we show theoretically that a permutation test based on the difference in means is identical to analysis of covariance if marginal covariate balance is completely attained. Our theoretical results and Monte Carlo simulation study suggest that the permutation test following Pocock-Simon's covariate-adaptive randomization can be a useful alternative to traditional population-based tests in a confirmatory randomized controlled trial with important prognostic factors. The proposed procedure is illustrated with modified data from the randomized placebo-controlled trial of pirfenidone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127470     DOI: 10.1080/10543400802527908

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  4 in total

1.  Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials.

Authors:  Steven D Lauzon; Viswanathan Ramakrishnan; Paul J Nietert; Jody D Ciolino; Michael D Hill; Wenle Zhao
Journal:  Stat Med       Date:  2020-05-04       Impact factor: 2.373

2.  Impact of minimal sufficient balance, minimization, and stratified permuted blocks on bias and power in the estimation of treatment effect in sequential clinical trials with a binary endpoint.

Authors:  Steven D Lauzon; Wenle Zhao; Paul J Nietert; Jody D Ciolino; Michael D Hill; Viswanathan Ramakrishnan
Journal:  Stat Methods Med Res       Date:  2021-11-29       Impact factor: 2.494

3.  Stratification and partial ascertainment of biomarker value in biomarker-driven clinical trials.

Authors:  Richard Simon
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

4.  Survival analysis following dynamic randomization.

Authors:  Xiaolong Luo; Mingyu Li; Gongjun Xu; Dongsheng Tu
Journal:  Contemp Clin Trials Commun       Date:  2016-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.